ArticleFrontiers in pharmacology2023

SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues.

Chukwunonso K Nwabufo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.